Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this year. Chugai revealed (PDF) the suspension of in-house development of the ...
To detect popular party drugs in human waste, researchers combined headspace solid-phase microextraction and solid-phase microextraction to detect these substances and their metabolites. South Korea ...
The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors. The FDA cleared the investigational new drug (IND) application for a phase 1 trial ...
A recent article published in Nature Communications described a simultaneous solid-phase recycling and alloying method to address the limitations of traditional alloy recycling through melting. The ...
The study demonstrates that aluminum manufacturing scrap can be transformed into metal alloys through a new method called solid phase alloying that perform on par with identical materials produced ...
Solid phase manufacturing can create new custom metal alloys through an innovative process called solid phase alloying, researchers report. Metal scrap can be directly transformed and upgraded into ...
ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk profile ...
The consequences can be costly, ranging from production downtime to compromised equipment and even safety hazards. Certainly, capacitors are indeed responsible for 30% of power electronics failures, ...
ZÜRICH--(BUSINESS WIRE)--CDR-Life Inc. today announced the initiation of enrollment for the Phase 1 trial of CDR404, its lead program in development as a precision immunotherapy for solid tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results